KNSA | Kiniksa Pharmaceuticals International, plc Class ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$93.29
+$2.49 (+2.74%)

Kiniksa Pharmaceuticals International, plc Class A (KNSA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA has sat above the 200 on the daily since May 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $93.29 vs 50 $79.67 / 200 $60.74
Projection
No cross projected
Test
No active test
Last cross
Golden cross 15 May 2025 ยท projected 12 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $92.24 vs 50 $56.92 / 200 $30.14
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 25 Dec 2023 ยท projected 27 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $93.29 vs 50 $81.61 / 200 $73.59
Projection
No cross projected
Test
No active test
Last cross
Golden cross 20 Mar 2025 ยท projected 28 bars out

Cross history

21
crosses on record since 2019
11 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
15 May 2025Golden steepdaily12 bars outNot tested
20 Mar 2025Golden4-hour28 bars outโ€”
3 Jan 2025Deathdaily27 bars outNot tested
18 Nov 2024Death4-hour28 bars outโ€”
16 Jul 2024Golden4-hour27 bars outโ€”

About KNSA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$37.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.